DUBLIN — Endo announced Tuesday that Par Pharmaceutical had begun shipping its generic of Seroquel XR (quetiapine fumarate extended-release) tablets. Par will have 180 days of market exclusivity for the 50-, 100-, 150-, 200- and 300-mg dosage strength tablets.
The drug had U.S. sales of $911 million for the 12 months ended September 2016, according to QuintilesIMS data. Profits from Par’s generic will be shared with its partners Hand Pharmaceuticals and Deerfield Generics.